Detailed view for PBANKA_1414600

Basic information

TDR Targets ID: 828171
Plasmodium berghei, inositol polyphosphate kinase, putative
Source Database / ID: 

pI: 9.8712 | Length (AA): 1042 | MW (Da): 123696 | Paralog Number: 0

Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0

Druggability Group : DG

Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable

Pfam domains

PF03770   Inositol polyphosphate kinase

Gene Ontology

Mouse over links to read term descriptions.
GO:0032958   inositol phosphate biosynthetic process  
GO:0016301   kinase activity  

Metabolic Pathways

Phosphatidylinositol signaling system (KEGG)

Structural information

Modbase 3D models:

There are 3 models calculated for this protein. More info on these models, including the models themselves is available at: Modbase

Target Beg Target End Template Template Beg Template End Identity Evalue Model Score MPQS zDope
18 1020 5nfv (A) 114 1148 19.00 0 1 0.743472 1.98
137 375 5w2i (A) 67 306 25.00 0 1 0.531467 -0.58
158 369 2iew (A) 29 352 33.00 0 0.98 0.447555 -0.42

Help me make sense of these data.

Target Beg: first modeled residue
Target End: last modeled residue
Template: template structure used for modelling (PDB accession and chain)
Template Beg: first template residue in target-template alignment
Template End: last template residue in target-template alignment
Identity: sequence identity
Evalue: E value for target-template hit
Model Score: GA341 score (>0.7 for reliable model)
MPQS: ModPipe Quality Score (>1.1 for reliable model)
zDope: zDope Score (negative for reliable model)

A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.

PDB Structures:

No structure availble in the PDB for this protein

Expression

Upregulation Percent Ranking Stage Dataset
Mid 40-60% percentile Gametocyte, 16 hs Trophozoite, 22 hs Schizont, Female gametocyte, Male gametocyte. Otto TD Yeoh LM
Upregulation Percent Ranking Stage Dataset
Lower 20-40% percentile Ookinete, 4 hs Ring, Erthyrocytic stages. Otto TD Yeoh LM
Show/Hide expression data references
  • Yeoh LM Comparative transcriptomics of female and male gametocytes in Plasmodium berghei and the evolution of sex in alveolates.
  • Otto TD A comprehensive evaluation of rodent malaria parasite genomes and gene expression.

Orthologs

Ortholog group members (OG5_128105)

Species Accession Gene Product
Brugia malayi Bm1_41900   Inositol polyphosphate kinase family protein
Candida albicans CaO19.8622   similar to InositolP6 kinase
Candida albicans CaO19.1007   similar to InositolP6 kinase
Caenorhabditis elegans CELE_F30A10.3   Protein F30A10.3
Dictyostelium discoideum DDB_G0278739   inositol phosphate kinase
Dictyostelium discoideum DDB_G0283863   hypothetical protein
Drosophila melanogaster Dmel_CG10082   CG10082 gene product from transcript CG10082-RA
Entamoeba histolytica EHI_051050   inositol hexaphosphate kinase, putative
Entamoeba histolytica EHI_106120   inositol hexakisphosphate kinase, putative
Homo sapiens ENSG00000161896   inositol hexakisphosphate kinase 3
Homo sapiens ENSG00000176095   inositol hexakisphosphate kinase 1
Leishmania braziliensis LbrM.14.0340   inositol polyphosphate kinase-like protein, putative
Leishmania donovani LdBPK_140340.1   inositol polyphosphate kinase-like protein, putative
Leishmania infantum LinJ.14.0340   inositol polyphosphate kinase-like protein, putative
Leishmania major LmjF.14.0340   inositol polyphosphate kinase-like protein, putative
Leishmania mexicana LmxM.14.0340   inositol polyphosphate kinase-like protein, putative
Loa Loa (eye worm) LOAG_03580   hypothetical protein
Loa Loa (eye worm) LOAG_11012   inositol polyphosphate kinase
Mus musculus ENSMUSG00000032594   inositol hexaphosphate kinase 1
Mus musculus ENSMUSG00000024210   inositol hexaphosphate kinase 3
Neospora caninum NCLIV_002970   hypothetical protein
Onchocerca volvulus OVOC1377  
Plasmodium berghei PBANKA_1414600   inositol polyphosphate kinase, putative
Plasmodium falciparum PF3D7_1316100   inositol polyphosphate kinase, putative
Plasmodium knowlesi PKNH_1416800   inositol polyphosphate kinase, putative
Plasmodium vivax PVX_122630   inositol polyphosphate kinase, putative
Plasmodium yoelii PY06556   inositol hexakisphosphate kinase
Saccharomyces cerevisiae YDR017C   inositol polyphosphate kinase KCS1
Trypanosoma brucei gambiense Tbg972.7.4970   inositol polyphosphate kinase-like protein, putative
Trypanosoma brucei Tb927.7.4400   inositol hexakisphosphate kinase
Trypanosoma congolense TcIL3000_7_3620   inositol polyphosphate kinase-like protein, putative
Trypanosoma cruzi TcCLB.506985.60   inositol polyphosphate kinase-like protein, putative
Trypanosoma cruzi TcCLB.504213.90   inositol polyphosphate kinase-like protein, putative
Toxoplasma gondii TGME49_208070   inositol polyphosphate kinase
Trichomonas vaginalis TVAG_476200   inositol polyphosphate kinase, putative
Trichomonas vaginalis TVAG_410270   transcription factor, putative
Trichomonas vaginalis TVAG_574700   kcs1 protein, putative
Trichomonas vaginalis TVAG_175750   kcs1 protein, putative

Essentiality

PBANKA_1414600 has direct evidence of essentiality
Gene/Ortholog Organism Phenotype Source Study
Tb927.7.4400 Trypanosoma brucei no significant loss or gain of fitness in bloodstream forms (3 days) alsford
Tb927.7.4400 Trypanosoma brucei significant gain of fitness in bloodstream forms (6 days) alsford
Tb927.7.4400 Trypanosoma brucei significant gain of fitness in procyclic forms alsford
Tb927.7.4400 Trypanosoma brucei significant gain of fitness in differentiation of procyclic to bloodstream forms alsford
PBANKA_1414600 this record Plasmodium berghei Dispensable plasmo
TGME49_208070 Toxoplasma gondii Probably essential sidik
Show/Hide essentiality data references
  • shigen Profiling of E. coli Chromosome (PEC) National Institute of Genetics, Japan
  • wormbase C. elegans RNAi experiments WormBase web site, http://www.wormbase.org, release WS170
  • yeastgenome Systematic deletion of yeast genes Saccharomyces Genome Database
  • nmpdr Genome-scale essentiality datasets from published studies (M. tuberculosis) National Microbial Pathogen Data Resource
  • alsford High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome Genome Res 2011, 21:915-924
  • gerdes Experimental determination and system-level analysis of essential genes in E. coli MG1655 Gerdes et al., J Bacteriol. 2003 185:5673-84
  • blattner Systematic mutagenesis of the E. coli (MG1655) genome J Bacteriol 2004, 186:4921-4930
  • plasmo Functional Profiling of a Plasmodium Genome Reveals an Abundance of Essential Genes. Bushell, Ellen, et al. "Functional profiling of a Plasmodium genome reveals an abundance of essential genes." Cell 170.2 (2017): 260-272.
  • sidik A Genome-wide CRISPR Screen in Toxoplasma Identifies Essential Apicomplexan Genes. Sidik, Saima M., et al. "A genome-wide CRISPR screen in toxoplasma identifies essential apicomplexan genes." Cell 166.6 (2016): 1423-1435.
  • goodall The Essential Genome of Escherichia coli K-12 (Transposon directed high-throughput mutagenesis) Goodall, Emily CA, et al. "The essential genome of Escherichia coli K-12." mBio 9.1 (2018): e02096-17.
  • keio Systematic single-gene knock-out mutants of E. coli K12 The Keio Collection
  • neb C. elegans RNAi phenotypes Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs

Phenotypes and Validation (curated)

We have no manually annotated phenotypes for this target. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please contact us.

Annotated validation

No validation data for this target

Associated compounds / Druggability

Known modulators for this target

No chemical compounds associated to this gene

Predicted associations

By orthology with druggable targets
Non orthologous druggable targets
By sequence similarity to non orthologous druggable targets
No additional associated druggable targets
Obtained from network model
No druggable targets predicted through repurposing network model

Assayability

Assay information

No assay information for this target.

Reagent availability

No reagent availability information for this target.

Bibliographic References

No literature references available for this target.

If you have references for this gene, please enter them in a user comment (below) or Contact us.

User comments

No user comments are available for this gene. Log in to add comments, or register.

Enter your comment

User ()
Gene identifier PBANKA_1414600 (Plasmodium berghei), inositol polyphosphate kinase, putative
Title for this comment
Comment